Freenome, Inc.: ADAR1 Capital Management, LLC amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
ADAR1 Capital Management, LLC amended its Schedule 13G stake filing for Freenome, Inc., according to SEC accession 0001104659-26-128738. The filing updates the investment firm's reported ownership position in the privately held cancer diagnostics company. Schedule 13G amendments are typically filed by passive investors to reflect changes in beneficial ownership. The specific size and percentage of the revised stake were not disclosed in the filing summary. Investors will watch for further 13G or 13D filings to gauge institutional interest in Freenome ahead of any financing or liquidity event.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Freenome, Inc., ADAR1 Capital Management, LLC